Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
Dauvilliers
Y
Y
Service de Neurologie, 80, Avenue Augustin Fliche, Hôpital Gui-de-Chauliac, 34295, Montpellier Cedex 5, France. y-dauvilliers@chu-montpellier.fr
Abril
B
B
Mas
E
E
Michel
F
F
Tafti
M
M
D000328:Adult; D002385:Cataplexy / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D047908:Intracellular Signaling Peptides and Proteins / Q000134:cerebrospinal fluid*; D009290:Narcolepsy / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000188:drug therapy*; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D000068797:Orexins; D016896:Treatment Outcome
C000596229:HCRT protein, human; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins